drugset / Trial / NCT00520377
Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective is the area of newly formed bone (%) as assessed by histomorphometry with either MD05 or beta-TCP.
Timeline
- Start
- 2005-01
- Primary completion
- 2007-12
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MD05 | Protein / enzyme biologic | — | — |
Indications
No indication recorded.